Abstract: Objective The rostral anterior cingulate cortex (rACC) is implicated in processing the emotional component of pain. N-methyl-D-aspartate receptors (NMDARs) are highly expressed in the rACC and mediate painrelated affect by activating a signaling pathway that involves cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and/or extracellular regulated kinase (ERK)/cAMP-response element-binding protein (CREB). The present study investigated the contributions of the NMDAR glycine site and GluN2B subunit to the activation of ERK and CREB both in vitro and in vivo in rat rACC. Methods Immunohistochemistry and Western blot analysis were used to separately assess the expression of phospho-ERK (pERK) and phospho-CREB (pCREB) in vitro and in vivo. Double immunostaining was also used to determine the colocalization of pERK and pCREB. Results Both bath application of NMDA in brain slices in vitro and intraplantar injection of formalin into the rat hindpaw in vivo induced significant up-regulation of pERK and pCREB in the rACC, which was inhibited by the NMDAR antagonist DL-2-amino-5-phospho-novaleric acid. Selective blockade of the NMDAR GluN2B subunit and the glycinebinding site, or degradation of endogenous D-serine, a co-agonist for the glycine site, significantly decreased the upregulation of pERK and pCREB expression in the rACC. Further, the activated ERK predominantly colocalized with CREB. Conclusion Either the glycine site or the GluN2B subunit of NMDARs participates in the phosphorylation of ERK and CREB induced by bath application of NMDA in brain slices or hindpaw injection of 5% formalin in rats, and these might be fundamental molecular mechanisms underlying pain affect.
Introduction
The encoding of the sensory and affective dimensions of pain involves different neural circuits [1] . The early medical literature reported that patients with anterior cingulate cortex (ACC) lobotomies still felt pain but found it less disturbing [2] . Considerable evidence suggests that the ACC has substantial connections with broad brain regions including secondary visual cortex, secondary auditory cortex, thalamus, amygdala, hippocampus [3] and primary and [4] . Such neuroanatomy also makes the ACC a candidate region that contributes to pain affect. Using hypnotic suggestion, Rainville and his colleagues found that activity within the ACC is correlated with the level of perceived unpleasantness when subjects are exposed to the same intensity of pain [4] , which provided the first direct evidence for a specific role of the ACC in the processing of pain affect. More recent studies further
showed that the rostral ACC (rACC), but not the caudal ACC, contributes to pain affect through glutamatergic activation within this region [5] [6] [7] .
A series of experiments in our lab revealed that the acquisition of formalin-induced conditioned place avoidance (CREB) signaling pathway [5] . Particularly, NMDARs play an indispensable role in the induction of pain affect [7, 8] . Functional NMDARs are heterodimers composed of one GluN1
and GluN2 subunit. GluN2A and GluN2B, subtypes of the GluN2 subunit, together with GluN1, are highly expressed in forebrain areas [9] , especially in the rACC [10] . Peripheral noxious stimuli elevate the expression of GluN2A and GluN2B subunits in the ACC [10] . Selective blockade of GluN2A and GluN2B subunits or the glycine site of NMDARs abolishes the acquisition of F-CPA [10, 11] . However, it remains unclear which NMDAR subunits or regulatory sites contribute to the cellular ERK-CREB signaling pathway in pain affect. In the present study, we investigated the effects of the NMDAR GluN2B subunit and glycine site on the activation of ERK and CREB in the rACC both in vitro and in vivo. according to our previous study [5] . The slices were then rapidly fixed in cold 4% paraformaldehyde for 60 min and rinsed in 0.01mol/L PBS for 6 × 10 min before immunostaining. [12] 20 min before formalin injection. The drug doses were selected based on our previous studies [5, 10, 11] . Either vehicle or drug was injected at a dose of 0.5 μL per hemisphere over a 5-min period. The syringe was left for an additional 5 min to minimize the spread of drug along the injection track. After that, the craniotomy was filled with sponge and the skin was sutured. and the blots were exposed to X-ray film for 1-10 min.
Immunohistochemistry

Intra-rACC drug infusion
Western blotting
Western blot analysis was performed at least three times, and consistent results were obtained. 
Quantification and statistics
Results
Glycine site and GluN2B subunit of NMDAR and ERK activation in vivo ERK phosphorylation is an indicator of ERK activation. Previous work from our lab
showed that up-regulation of pERK following intraplantar formalin injection is NMDAR-dependent and necessary for the acquisition of F-CPA [5] . To investigate the roles of the glycine site and GluN2B subunit of NMDARs in formalin nociceptive stimulation-induced ERK activation, appropriate ligands were microinjected into the rACC 20 min before intraplantar injection of 5% formalin. ERK activation was tested by Western blot. Consistent with our previous finding, the nociceptive stimulation led to a robust increase in pERK level but no significant change in total ERK level (Fig. 1A) . Here, we pooled the bands for pERK1 and pERK2 and the bands for tERK1 and tERK2 for statistical analysis (Fig. 1B) . Intra-rACC injection of the NMDAR antagonist APV, the glycine site antagonist 7-CK, DAAO that degrades endogenous D-serine degradation, the NM-DAR GluN2B antagonist ifenprodil, or the ERK kinase MEK inhibitor PD98059 before formalin injection significantly suppressed formalin-induced ERK activation (Fig.   1A , B), while DMSO (10%, 0.6 µL/side, vehicle for ifenprodil and PD98059) had no such effect (Fig. 1A, B) . The total ERK level remained unchanged under all treatment conditions (Fig. 1A) . Fig. 2A, B, I ), in the presence of 1 µmol/L TTX to block action potentials. The up-regulated pERK was attenuated by interfering with NMDARs with APV, 7-CK, DAAO, or ifenprodil ( Fig. 2D-I) . Pretreatment with PD98059, the ERK kinase inhibitor, significantly decreased but did not eliminate ERK activation (Fig. 2H, I ). 
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Substantial evidence shows that CREB plays a crucial role in the formation of long-term potentiation (LTP) which underlies the basis of long-term memory and associative learning. Since LTP can be induced in ACC slices [13, 14] and the essence of the F-CPA model is associative learning, we considered that CREB might be a downstream target of activated ERK induced by NMDA application or formalin injection. To test this, we first determined whether activated ERK and CREB are expressed in the same neurons in the rACC. Double immunostaining showed that bath ap- plication of NMDA induced robust activation of ERK and CREB, and activated ERK was predominantly colocalized with pCREB in the rACC slice (Fig. 3 ).
In addition, NMDA markedly increased the number of pCREB-positive cells in rACC slices (Fig. 4A, I ). Meanwhile, PD98059, a MEK inhibitor that blocks ERK activation, prevented the phosphorylation of CREB induced by NMDA in rACC slices (Fig. 4H, I ). These results are consistent with previous evidence that activated ERK translocates to the nucleus, and phosphorylates and switches on the transcriptional activity of CREB [15] . Moreover, APV, 7-CK, DAAO and ifenprodil all inhibited the CREB activation induced by NMDA application in rACC slices (Fig. 4D-G, I ).
Glycine site and GluN2B subunit of NMDAR and CREB activation in vivo
The expression of pCREB and the contributions of the NMDAR glycine site and GluN2B subunit to CREB activation were also confirmed in vivo.
Intraplantar formalin injection induced a significant increase of pCREB expression in the rACC (Fig. 5A) , and this was blocked by pre-administration of the NMDAR antagonist APV or the ERK kinase inhibitor PD98059 (Fig. 5A) , suggesting that formalin injection-induced CREB phosphorylation is NMDAR-and/or ERK cascadedependent. Also, interference with NMDARs by 7-CK, DAAO or ifenprodil suppressed the nociception-induced up-regulation of pCREB (Fig. 5A, B) . 
Discussion
In the present study, we showed that (1) bath application of NMDA or intraplantar injection of formalin induced significant activation of ERK and CREB within the rACC in rats; (2) this up-regulation of pERK and pCREB expres- [5, 8, 11] . Thus, we conclude that the glycine site and GluN2B subunit activation coupled to intracellular ERK/CREB signaling is a key factor in the encoding of the affective dimension of pain.
The NMDAR plays a crucial role in a variety of physiological and pathological processes, including different forms of LTP, learning/memory, pain hyperalgesia, neurodegeneration and psychosis [16] [17] [18] [19] . Morphological studies have shown that NMDARs including the GluN1, GluN2A and GluN2B subtypes are highly expressed in the ACC. Accumulating evidence shows that activation of NMDARs increases postsynaptic Ca 2+ concentration [20] and consequently activates multiple signaling cascades such as the ERK pathway [21] . Elevated Ca 2+ increases intracellular cAMP levels, leading to PKA activation and therefore phosphorylates ERK through Rap1, then B-Raf [15] . Our studies in vitro and in vivo showed that bath application of NMDA or intraplantar injection of formalin increased pERK expression in the rat rACC, and this was blocked by APV, implicating NMDARs in ERK activation, which is consistent with our and other groups' findings [5, [22] [23] [24] [25] [26] [27] .
In particular, our present data demonstrated that 7-CK or DAAO suppressed the up-regulation of pERK induced by NMDA or nociceptive stimulation, suggesting involvement of the NMDAR glycine site in ERK activation. Ifenprodil, a GluN2B antagonist, also reduced the up-regulation of pERK induced by NMDA, indicating that GluN2B subunit couples to intracellular signaling and then activates ERK, which is consistent with the finding of Krapivinsky et al. [28] that NMDARs mediate ERK activity via interaction of the GluN2B subunit with RasGRF1 [28] . However, Kim et al. [29] showed that the NMDAR GluN2B subunit is coupled to inhibition rather than activation of Ras-ERK. It is difficult to completely explain the discrepancy at present, except to note the differences in brain regions (hippocampus vs rACC) and neuronal models (cultured neurons vs slices).
Ca 2+ influx through NMDARs can also stimulate neuronal gene expression via transcription factors [30] . Our previous study showed that CREB is one of the downstream targets of the ERK signaling pathway in rACC neurons, and that it triggers CREB-mediated transcription of genes such as c-fos during the induction of pain affect [5, 31] . Here, we showed that NMDA application and formalin injection which induced ERK activation were also coupled to CREB phosphorylation. Importantly, pERK was largely colocalized with pCREB in the rACC slice. Moreover, our data also showed that blockade of the glycine site or GluN2B subunit of NMDARs significantly reduced the upregulation of phospho-CREB induced by NMDA perfusion of brain slices or by formalin injection in rat hindpaw, suggesting that both the glycine site and GluN2B subunits in the rACC are required for CREB activation. This finding is in agreement with numerous studies describing NMDARdependent processes [28, 32, 33] . Phosphorylation of the GluN1 subunit at Ser897 or tyrosine phosphorylation of GluN2B might play important roles when coupled to ERK-CREB signaling [34, 35] . However, another study reported that blockade of the GluN2B subunit does not inhibit ischemiainduced phosphorylation of CREB and the subsequent upregulation of CREB target genes such as cpg15 and bdnf [36] .
This discrepancy may be due to the differences in brain regions (rACC vs hippocampus) and animal models (inflammatory pain vs ischemia by vessel occlusion). Besides, target genes that are regulated by CREB-mediated transcription in the rACC and the regulation of these genes by different NMDAR subunits remain to be investigated. It should be noted that the expression of pCREB was more intensive than that of pERK, and was widely distributed in the rACC, indicating the pERK-independent activation of pCREB. -dependent activation of CREB [37, 38] .
Importantly, a new finding of the present study was ERK signaling in mice [39] . It is clear that high levels of Dserine exist in the mammalian brain [40] . Immunohistochemical studies have revealed an overlapping distribution of D-serine and NMDAR immunoreactivity in the forebrain [41, 42] . Extracellular D-serine levels are similar or even 
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higher than glycine levels in some areas, as measured by in vivo microdialysis [43] . Furthermore, D-serine is functionally 100-fold more effective than glycine at potentiating NMDAR-mediated synaptic action in hypoglossal motoneurons [44] . A series of studies has suggested that D-serine is the endogenous ligand for glycine sites of the NMDAR in some regions, such as the forebrain, telencephalon and developing cerebellum, whereas glycine predominates in other regions such as adult cerebellum, olfactory bulb, and hindbrain [41, 42, 45, 46] . Given that both competitive and non- (Fig. 6) . Given that the glycine site, GluN2B, and ERK within the rACC are all indispensable for the induction of pain affect [5, 10, 11] , the coupling of activation of the glycine site or the GluN2B subunit to the ERK-CREB signaling pathway might be the molecular and cellular mechanism underlying affective pain.
